TY - JOUR AU - Bray, F. AU - Ferlay, J. AU - Soerjomataram, I. AU - Siegel, R. L. AU - Torre, L. A. AU - Jemal, A. PY - 2018 DA - 2018// TI - Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries JO - CA Cancer J Clin VL - 68 UR - https://doi.org/10.3322/caac.21492 DO - 10.3322/caac.21492 ID - Bray2018 ER - TY - JOUR AU - Medina-Franco, H. AU - Cortes-Gonzalez, R. AU - Lambreton-Hinojosa, F. AU - Fimbres-Morales, A. AU - Vargas-Siordia, J. C. PY - 2017 DA - 2017// TI - Neoadjuvant chemotherapy increases R0 cytoreduction rate but does not improve final outcome in advanced epithelial ovarian cancer JO - Ann Surg Oncol VL - 24 UR - https://doi.org/10.1245/s10434-016-5704-3 DO - 10.1245/s10434-016-5704-3 ID - Medina-Franco2017 ER - TY - JOUR AU - Kessous, R. AU - Laskov, I. AU - Abitbol, J. AU - Bitharas, J. AU - Yasmeen, A. AU - Salvador, S. PY - 2017 DA - 2017// TI - Clinical outcome of neoadjuvant chemotherapy for advanced ovarian cancer JO - Gynecol Oncol VL - 144 UR - https://doi.org/10.1016/j.ygyno.2016.12.017 DO - 10.1016/j.ygyno.2016.12.017 ID - Kessous2017 ER - TY - JOUR AU - Vergote, I. AU - Bois, A. AU - Amant, F. AU - Heitz, F. AU - Leunen, K. AU - Harter, P. PY - 2013 DA - 2013// TI - Neoadjuvant chemotherapy in advanced ovarian cancer: on what do we agree and disagree? JO - Gynecol Oncol VL - 128 UR - https://doi.org/10.1016/j.ygyno.2012.09.013 DO - 10.1016/j.ygyno.2012.09.013 ID - Vergote2013 ER - TY - JOUR AU - Nishio, S. AU - Ushijima, K. PY - 2020 DA - 2020// TI - Clinical significance of primary debulking surgery and neoadjuvant chemotherapy-interval debulking surgery in advanced ovarian cancer JO - Jpn J Clin Oncol VL - 50 UR - https://doi.org/10.1093/jjco/hyaa015 DO - 10.1093/jjco/hyaa015 ID - Nishio2020 ER - TY - JOUR AU - Lv, X. AU - Cui, S. AU - Zhang, X. AU - Ren, C. PY - 2020 DA - 2020// TI - Efficacy and safety of neoadjuvant chemotherapy versus primary debulking surgery in patients with ovarian cancer: a meta-analysis JO - J Gynecol Oncol VL - 31 UR - https://doi.org/10.3802/jgo.2020.31.e12 DO - 10.3802/jgo.2020.31.e12 ID - Lv2020 ER - TY - JOUR AU - Vergote, I. AU - Tropé, C. G. AU - Amant, F. AU - Kristensen, G. B. AU - Ehlen, T. AU - Johnson, N. PY - 2010 DA - 2010// TI - Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cance JO - N Engl J Med VL - 363 UR - https://doi.org/10.1056/NEJMoa0908806 DO - 10.1056/NEJMoa0908806 ID - Vergote2010 ER - TY - JOUR AU - Kehoe, S. AU - Hook, J. AU - Nankivell, M. AU - Jayson, G. C. AU - Kitchener, H. AU - Lopes, T. PY - 2015 DA - 2015// TI - Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial JO - Lancet VL - 386 UR - https://doi.org/10.1016/S0140-6736(14)62223-6 DO - 10.1016/S0140-6736(14)62223-6 ID - Kehoe2015 ER - TY - JOUR AU - Onda, T. AU - Satoh, T. AU - Ogawa, G. AU - Saito, T. AU - Kasamatsu, T. AU - Nakanishi, T. PY - 2020 DA - 2020// TI - Comparison of survival between primary debulking surgery and neoadjuvant chemotherapy for stage III/IV ovarian, tubal and peritoneal cancers in phase III randomised trial JO - Eur J Cancer VL - 130 UR - https://doi.org/10.1016/j.ejca.2020.02.020 DO - 10.1016/j.ejca.2020.02.020 ID - Onda2020 ER - TY - JOUR AU - Melamed, A. AU - Hinchcliff, E. M. AU - Clemmer, J. T. AU - Bregar, A. J. AU - Uppal, S. AU - Bostock, I. PY - 2016 DA - 2016// TI - Trends in the use of neoadjuvant chemotherapy for advanced ovarian cancer in the United States JO - Gynecol Oncol VL - 143 UR - https://doi.org/10.1016/j.ygyno.2016.09.002 DO - 10.1016/j.ygyno.2016.09.002 ID - Melamed2016 ER - TY - JOUR AU - Meyer, L. A. AU - Cronin, A. M. AU - Sun, C. C. AU - Bixel, K. AU - Bookman, M. A. AU - Cristea, M. C. PY - 2016 DA - 2016// TI - Use and effectiveness of neoadjuvant chemotherapy for treatment of ovarian Cancer JO - J Clin Oncol VL - 34 UR - https://doi.org/10.1200/JCO.2016.68.1239 DO - 10.1200/JCO.2016.68.1239 ID - Meyer2016 ER - TY - JOUR AU - Fago-Olsen, C. L. AU - Ottesen, B. AU - Kehlet, H. AU - Antonsen, S. L. AU - Christensen, I. J. AU - Markauskas, A. PY - 2014 DA - 2014// TI - Does neoadjuvant chemotherapy impair long-term survival for ovarian cancer patients? A nationwide danish study JO - Gynecol Oncol VL - 132 UR - https://doi.org/10.1016/j.ygyno.2013.11.035 DO - 10.1016/j.ygyno.2013.11.035 ID - Fago-Olsen2014 ER - TY - JOUR AU - Bian, C. AU - Yao, K. AU - Li, L. AU - Yi, T. AU - Zhao, X. PY - 2016 DA - 2016// TI - Primary debulking surgery vs. neoadjuvant chemotherapy followed by interval debulking surgery for patients with advanced ovarian cancer JO - Arch Gynecol Obstet VL - 293 UR - https://doi.org/10.1007/s00404-015-3813-z DO - 10.1007/s00404-015-3813-z ID - Bian2016 ER - TY - JOUR AU - May, T. AU - Comeau, R. AU - Sun, P. AU - Kotsopoulos, J. AU - Narod, S. A. AU - Rosen, B. PY - 2017 DA - 2017// TI - A comparison of survival outcomes in advanced serous ovarian cancer patients treated with primary debulking surgery versus neoadjuvant chemotherapy JO - Int J Gynecol Cancer VL - 27 UR - https://doi.org/10.1097/IGC.0000000000000946 DO - 10.1097/IGC.0000000000000946 ID - May2017 ER - TY - JOUR AU - Lee, Y. J. AU - Chung, Y. S. AU - Lee, J. Y. AU - Nam, E. J. AU - Kim, S. W. AU - Kim, S. PY - 2018 DA - 2018// TI - Impact of the time interval from completion of neoadjuvant chemotherapy to initiation of postoperative adjuvant chemotherapy on the survival of patients with advanced ovarian cancer JO - Gynecol Oncol VL - 148 UR - https://doi.org/10.1016/j.ygyno.2017.11.023 DO - 10.1016/j.ygyno.2017.11.023 ID - Lee2018 ER - TY - JOUR AU - Siesto, G. AU - Cavina, R. AU - Romano, F. AU - Vitobello, D. PY - 2018 DA - 2018// TI - Primary debulking surgery versus neoadjuvant chemotherapy in advanced epithelial ovarian cancer: a propensity-matched analysis JO - Am J Clin Oncol VL - 41 UR - https://doi.org/10.1097/COC.0000000000000262 DO - 10.1097/COC.0000000000000262 ID - Siesto2018 ER - TY - JOUR AU - Bae, H. S. AU - Kim, H. J. AU - Hong, J. H. AU - Lee, J. K. AU - Lee, N. W. AU - Song, J. Y. PY - 2014 DA - 2014// TI - Obesity and epithelial ovarian cancer survival: a systematic review and meta-analysis JO - J Ovarian Res VL - 7 UR - https://doi.org/10.1186/1757-2215-7-41 DO - 10.1186/1757-2215-7-41 ID - Bae2014 ER - TY - JOUR AU - Kotsopoulos, J. AU - Moody, J. R. AU - Fan, I. AU - Rosen, B. AU - Risch, H. A. AU - McLaughlin, J. R. PY - 2012 DA - 2012// TI - Height, weight, BMI and ovarian cancer survival JO - Gynecol Oncol VL - 127 UR - https://doi.org/10.1016/j.ygyno.2012.05.038 DO - 10.1016/j.ygyno.2012.05.038 ID - Kotsopoulos2012 ER - TY - JOUR AU - Lydiksen, L. AU - Jensen-Fangel, S. AU - Blaakaer, J. PY - 2014 DA - 2014// TI - Is it possible to define an optimal time for chemotherapy after surgery for ovarian cancer? JO - Gynecol Oncol VL - 133 UR - https://doi.org/10.1016/j.ygyno.2014.04.004 DO - 10.1016/j.ygyno.2014.04.004 ID - Lydiksen2014 ER - TY - JOUR AU - Seagle, B. L. AU - Butler, S. K. AU - Strohl, A. E. AU - Nieves-Neira, W. AU - Shahabi, S. PY - 2017 DA - 2017// TI - Chemotherapy delay after primary debulking surgery for ovarian cancer JO - Gynecol Oncol VL - 144 UR - https://doi.org/10.1016/j.ygyno.2016.11.022 DO - 10.1016/j.ygyno.2016.11.022 ID - Seagle2017 ER - TY - JOUR AU - Hofstetter, G. AU - Concin, N. AU - Braicu, I. AU - Chekerov, R. AU - Sehouli, J. AU - Cadron, I. PY - 2013 DA - 2013// TI - The time interval from surgery to start of chemotherapy significantly impacts prognosis in patients with advanced serous ovarian carcinoma - analysis of patient data in the prospective OVCAD study JO - Gynecol Oncol VL - 131 UR - https://doi.org/10.1016/j.ygyno.2013.07.086 DO - 10.1016/j.ygyno.2013.07.086 ID - Hofstetter2013 ER - TY - JOUR AU - Searle, G. AU - Pounds, R. AU - Phillips, A. AU - Kehoe, S. AU - Balega, J. AU - Singh, K. PY - 2020 DA - 2020// TI - Prolonged interruption of chemotherapy in patients undergoing delayed debulking surgery for advanced high grade serous ovarian cancer is associated with a worse prognosis JO - Gynecol Oncol VL - 158 UR - https://doi.org/10.1016/j.ygyno.2020.04.048 DO - 10.1016/j.ygyno.2020.04.048 ID - Searle2020 ER - TY - JOUR AU - Gupta, M. AU - Patel, S. M. AU - Arora, R. AU - Tiwari, R. AU - Dave, P. AU - Desai, A. PY - 2020 DA - 2020// TI - Does preoperative CA-125 cutoff value and percent reduction in CA-125 levels correlate with surgical and survival outcome after neoadjuvant chemotherapy in patients with advanced-stage ovarian cancer? - our experience from a tertiary cancer institute JO - South Asian J Cancer VL - 9 UR - https://doi.org/10.4103/sajc.sajc_53_17 DO - 10.4103/sajc.sajc_53_17 ID - Gupta2020 ER - TY - JOUR AU - Akilli, H. AU - Rahatli, S. AU - Tohma, Y. A. AU - Karakas, L. A. AU - Altundag, O. AU - Ayhan, A. PY - 2018 DA - 2018// TI - Effect of increased number of neoadjuvant chemotherapy cycles on tumor resectability and pathologic response in advanced stage epithelial ovarian cancer JO - J BUON VL - 23 ID - Akilli2018 ER - TY - JOUR AU - Liu, Y. L. AU - Zhou, Q. C. AU - Iasonos, A. AU - Chi, D. S. AU - Zivanovic, O. AU - Sonoda, Y. PY - 2020 DA - 2020// TI - Pre-operative neoadjuvant chemotherapy cycles and survival in newly diagnosed ovarian cancer: what is the optimal number? A memorial sloan kettering cancer center team ovary study JO - Int J Gynecol Cancer VL - 30 UR - https://doi.org/10.1136/ijgc-2020-001641 DO - 10.1136/ijgc-2020-001641 ID - Liu2020 ER - TY - JOUR AU - Zhang, G. N. PY - 2020 DA - 2020// TI - Neoadjuvant chemotherapy followed by interval debulking surgery for advanced ovarian cancer: problems and considerations JO - J Cancer Control Treat VL - 33 ID - Zhang2020 ER -